| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Pergonal (menotropins) Injection, Serono, NDA 17-646/S-049 Repronex (menotropins for injection), 75 and 150 IU injection, Ferring NDA 21-047 08/27/99 9/2/99 9/2/99 Repronex Indication: for use in conjunction with hCG for multiple follicular development and ovulation induction in patients who have previously received pituitary suppression. |
|
© 2009 Betterchem.com
|